Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Mapisa369 Scales New Heights: Ashok Choudhary Recognized by Gujarat CM for Quality Standards Business
  • World Designing Forum Sets Remarkable Benchmark for New Fashion Industry on National Handloom Day Lifestyle
  • Inauguration of Electric Vehicles in TATA Steel Business
  • HRANI Set to Host 3rd Convention: “उदयन् भारतम् Rising India – Shaping a New Era in Hospitality And Tourism” Health
  • IIT Delhi Opens Admissions for Batch 2 of Online PG Diploma in Advanced Communication Engineering with Quantum and AI Integration Education
  • Magsmen and VIT AP Partnership: A Catalyst for Innovation and Entrepreneurial Success Business
  • BuySM.com – An Affordable & Cold Storage Super Speciality Medicine Business
  • GIBS Bangalore, successfully organized the International Conclave on Neo Business Practices for the Evolving World Press Release

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Sahi Unveils Scalper 2.0 — A High-Performance Upgrade Built with Traders, For Real Markets Business
  • How This Company is on Track to become the #1 Content Creation Platform on YouTube. Business
  • Radha TMT is hoping to go big with exports, Eyeing increase in demand post COVID-19 lockdown Business
  • Two days High Performance National Design Summit inaugurated Business
  • Tasva, the Indian Menswear Brand, Launches Its Flagship Store in Pune with Bollywood Actor Vijay Varma Business
  • How to navigate Indian stocks amid the geopolitical war Business

Recent Posts

  • Pure Nutrition Comes Onboard as the Official Sports Nutrition Partner for IPL Frontrunner – Chennai Super Kings
  • First Gujarati Woman Producer Chanda Patel Represents WIFPA at Oscars 2026, Promotes Film Tera Mera Nata
  • Ekta World Introduces Ekta Victoria, a Premium Residential Address Near Pali Hill
  • Sarvajanik University Promotes Inclusivity through ‘Samantvam’ Initiative
  • SOMANY Ceramics Continues to Build Upon Its Waste Tile Reuse Initiative on Global Recycling Day 2026

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Cricket Academy of Pathans (CAP)’s 32nd centre launched by Yusuf Pathan in Malihabad (Uttar Pradesh) Business
  • SamBlogs Becomes the First SEO Agency to Help Clients Rank in Perplexity, Gemini, ChatGPT, and Beyond Business
  • MeshApp : Making Doctors’ Lives Easier with Easy Access, Smart Data, and Better Communication Business
  • Premium Babycare Brand – StarAndDaisy, ropes in Ameesha Patel as its Brand Ambassador Business
  • VCare’s Hair Transplantation Ensures To Completely Reverse Baldness Business
  • Fashion and Lifestyle Brand YOULRY.COM Launches “The Bella Donna Feat. EPR and Iman” – A Unique Duet of Rap and Folk Lifestyle
  • Sapnon Ke Sawaari: Aahwahan’s Initiative to Transform Lives with Automated Wheelchairs Lifestyle
  • Decoding Financial Freedom through Stock market with Vibhor Varshney Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme